Difference between revisions of "Talk:Programmed death-ligand 1"

Jump to navigation Jump to search
no edit summary
Line 9: Line 9:
*2018 meta-analysis: PD-L1 is a poor prognosticator in RCC (HR~2.76)[https://www.ncbi.nlm.nih.gov/pubmed/29362922]
*2018 meta-analysis: PD-L1 is a poor prognosticator in RCC (HR~2.76)[https://www.ncbi.nlm.nih.gov/pubmed/29362922]


==CPS and TPS==
CPS in lymph nodes:
https://pubmed.ncbi.nlm.nih.gov/35420378/
https://pmc.ncbi.nlm.nih.gov/articles/PMC7413953/
https://pmc.ncbi.nlm.nih.gov/articles/PMC10078903/
https://surgexppathol.biomedcentral.com/articles/10.1186/s42047-019-0033-z


==References==
==References==
{{Reflist|1}}
{{Reflist|1}}
48,802

edits

Navigation menu